- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Nurse Clinic Model Proven Cost Effective and Efficacious Method for Improving Diabetes Care
To further develop an already existing Nurse Clinic model at Kaiser Permanente Riverside, researchers in this study developed an internal specialized diabetes training program using the American Association of Diabetes Educators and American Diabetes Association guidelines to improve effectiveness.
To further develop an already existing Nurse Clinic model at Kaiser Permanente Riverside, researchers in this study developed an internal specialized diabetes training program using the American Association of Diabetes Educators and American Diabetes Association guidelines to improve effectiveness. Ten, 3-hour training sessions were delivered to registered nurses over the course of 10 months in 5 clinics. Nurses engaged in face-to-face visits with patients as well as phone follow-ups for up to 8 weeks or until the patient had achieved glycemic goal. Some of the barriers and topics that nurses faced were medication adherence strategies, self-management skills, and lipid and hypertension management.
Not only were the glycemic control rate outcomes improved across all 5 clinics from 5% to 11%, but the impact that the refined Nurse Clinic model had on financial outcomes was improved as well. Researchers noted that the usual cost per patient is estimated to be $202/physician visit, whereas the nurse visit equated to approximately $30 per face-to-face visit and $20 per follow-up phone call. Additionally, the authors of the study noted that a department survey showed a 92% provider satisfaction with the training provided, and that “the specialized diabetes training program further enhanced the value of clinical outcomes in a patient-centered medical home."
To read more about this study, please visit the American Diabetes Association’s website.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
